Glutamic acid decarboxylase inhibition and ultrastructural changes by the convulsant drug allylglycine.
D000410:Alanine Transaminase / Q000037:antagonists & inhibitors; D000475:Alkenes / Q000494:pharmacology*; D000596:Amino Acids / Q000494:pharmacology*; D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002540:Cerebral Cortex / Q000201:enzymology* / Q000473:pathology; D005971:Glutamates; D005998:Glycine; D008025:Ligases / Q000037:antagonists & inhibitors*; D008854:Microscopy, Electron; D009411:Nerve Endings / Q000201:enzymology / Q000473:pathology*; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000201:enzymology*; D000637:Transaminases / Q000037:antagonists & inhibitors*
D000475:Alkenes; D000596:Amino Acids; D000613:Aminobutyrates; D005971:Glutamates; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D002262:Carboxy-Lyases; D008025:Ligases; D005998:Glycine